Venturi Wealth Management LLC lowered its stake in HealthSouth Corp (NYSE:HLS) by 10.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 113,349 shares of the company’s stock after selling 13,890 shares during the period. Venturi Wealth Management LLC owned approximately 0.12% of HealthSouth worth $5,208,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently modified their holdings of the company. First Mercantile Trust Co. boosted its stake in shares of HealthSouth by 18.8% during the second quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock valued at $132,000 after purchasing an additional 430 shares in the last quarter. Acrospire Investment Management LLC lifted its stake in shares of HealthSouth by 64.7% in the second quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock worth $136,000 after acquiring an additional 1,100 shares during the period. Advisor Group Inc. lifted its stake in shares of HealthSouth by 33.8% in the second quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock worth $149,000 after acquiring an additional 781 shares during the period. Petrus Trust Company LTA acquired a new position in shares of HealthSouth in the second quarter worth approximately $210,000. Finally, HL Financial Services LLC acquired a new position in shares of HealthSouth in the second quarter worth approximately $213,000. Institutional investors own 93.37% of the company’s stock.
In other news, Director Yvonne M. Curl purchased 1,000 shares of the company’s stock in a transaction dated Wednesday, November 1st. The shares were purchased at an average price of $45.95 per share, with a total value of $45,950.00. Following the transaction, the director now directly owns 64,144 shares of the company’s stock, valued at $2,947,416.80. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. 1.60% of the stock is owned by corporate insiders.
HealthSouth Corp (NYSE HLS) traded down $0.37 during mid-day trading on Friday, reaching $49.40. The company’s stock had a trading volume of 1,180,700 shares, compared to its average volume of 901,328. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.34 and a current ratio of 1.34. HealthSouth Corp has a twelve month low of $38.24 and a twelve month high of $50.41. The stock has a market capitalization of $4,892.93, a PE ratio of 17.84, a P/E/G ratio of 1.83 and a beta of 0.54.
HealthSouth (NYSE:HLS) last posted its quarterly earnings data on Thursday, October 26th. The company reported $0.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.01. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. The business had revenue of $995.60 million for the quarter, compared to analysts’ expectations of $985.75 million. During the same quarter in the previous year, the firm earned $0.65 earnings per share. The business’s revenue was up 7.4% on a year-over-year basis. equities research analysts forecast that HealthSouth Corp will post 2.72 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.02%. HealthSouth’s dividend payout ratio is presently 36.36%.
A number of equities analysts recently commented on HLS shares. Stephens started coverage on HealthSouth in a research note on Thursday, August 31st. They issued an “overweight” rating and a $53.00 price objective on the stock. ValuEngine downgraded HealthSouth from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Royal Bank of Canada reiterated a “buy” rating and issued a $55.00 target price on shares of HealthSouth in a report on Wednesday, September 6th. KeyCorp restated a “hold” rating on shares of HealthSouth in a report on Thursday, September 7th. Finally, Piper Jaffray Companies restated a “hold” rating and set a $50.00 price objective on shares of HealthSouth in a report on Sunday, September 17th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $51.75.
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth and related companies with MarketBeat.com's FREE daily email newsletter.